These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9847926)

  • 41. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1993 Sep; 58(168):46514-23. PubMed ID: 10128335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of FDA advisory on reported vacuum-assisted delivery and morbidity.
    Ross MG; Fresquez M; El-Haddad MA
    J Matern Fetal Med; 2000; 9(6):321-6. PubMed ID: 11243287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.
    Duggirala HJ; Herz ND; Caños DA; Sullivan RA; Schaaf R; Pinnow E; Marinac-Dabic D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):87-93. PubMed ID: 22095760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology of silicone-gel breast implants.
    Brown SL
    Epidemiology; 2002 May; 13 Suppl 3():S34-9. PubMed ID: 12071482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Silicone gel breast implants and connective tissue disease--a comprehensive review.
    Bar-Meir E; Eherenfeld M; Shoenfeld Y
    Autoimmunity; 2003 Jun; 36(4):193-7. PubMed ID: 14563011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety concerns about breast implants persist.
    Moynihan R
    BMJ; 2003 Oct; 327(7421):947. PubMed ID: 14576229
    [No Abstract]   [Full Text] [Related]  

  • 51. Minimally invasive endometrial ablation device complications and use outside of the manufacturers' instructions.
    Brown J; Blank K
    Obstet Gynecol; 2012 Oct; 120(4):865-70. PubMed ID: 22996104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment, Complications, and Surveillance of Breast Implants: Making Sense of 2022 FDA Breast Implant Guidance.
    Le-Petross HT; Scoggins ME; Clemens MW
    J Breast Imaging; 2023 May; 5(3):360-372. PubMed ID: 38416893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast implant surveillance reports to the U.S. Food and Drug Administration: maternal-child health problems.
    Brown SL; Todd JF; Cope JU; Sachs HC
    J Long Term Eff Med Implants; 2006; 16(4):281-90. PubMed ID: 17073570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FDA panel approves one make of silicone breast implant in the US.
    Moynihan R
    BMJ; 2005 Apr; 330(7497):919. PubMed ID: 15845957
    [No Abstract]   [Full Text] [Related]  

  • 55. Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.
    Lalani C; Kunwar EM; Kinard M; Dhruva SS; Redberg RF
    JAMA Intern Med; 2021 Sep; 181(9):1217-1223. PubMed ID: 34309624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infusion pump adverse events: experience from medical device reports.
    Brown SL; Morrison AE; Parmentier CM; Woo EK; Vishnuvajjala RL
    J Intraven Nurs; 1997; 20(1):41-9. PubMed ID: 9060364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Silicone gel-filled breast implants and breast cancer--an update and safety].
    Winkler E; Regev E; Bar-Meir E; Orenstein A
    Harefuah; 2004 Mar; 143(3):222-6, 244. PubMed ID: 15065364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silicone breast implants: lessons from the USA.
    Lancet; 2012 Jan; 379(9811):93. PubMed ID: 22243811
    [No Abstract]   [Full Text] [Related]  

  • 59. FDA finds breast implants to be safe but calls for better follow-up.
    Stafford N
    BMJ; 2011 Sep; 343():d5664. PubMed ID: 21896602
    [No Abstract]   [Full Text] [Related]  

  • 60. A pharmaceutical manufacturer's perspective on reporting adverse drug experiences.
    Sullivan JW
    Am J Hosp Pharm; 1990 Jun; 47(6):1342-5. PubMed ID: 2368728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.